aTyr Pharma, Inc. (LIFE) Financials

LIFE Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 122.1 million 31.6 million
2023-09-30 125.1 million 26.9 million
2023-06-30 132.7 million 26.7 million
2023-03-31 136.8 million 27.1 million

LIFE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -11.1 million 659000
2023-09-30 -10.1 million 664000
2023-06-30 -14.4 million 658000
2023-03-31 -1.8 million 619000

LIFE Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -14.8 million
2023-09-30 -11.3 million
2023-06-30 -12.3 million
2023-03-31 -12.0 million

LIFE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 98.2 million - 15.1 million
2023-09-30 105.6 million - 15.2 million
2023-06-30 108.6 million - 15.4 million
2023-03-31 114.4 million - 14.3 million

LIFE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 59.3 million
2023-09-30 57.9 million
2023-06-30 55.1 million
2023-03-31 41.9 million

LIFE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 17000 12.8 million 3.2 million -407000
2023-09-30 557000 10.3 million 2.6 million -
2023-06-30 2.4 million 9.8 million 3.7 million -
2023-03-31 1.2 million 9.4 million 3.4 million -

LIFE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 407000
2023-09-30 353000 993000
2023-06-30 - 586000
2023-03-31 - 755000

LIFE

Price: $1.70

52 week price:
1.08
2.70

Earnings Per Share: -0.94 USD

P/E Ratio: -1.77

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 171300

Ebitda: -10.7 million

Market Capitalization: 113.8 million

Links: